Literature DB >> 7563224

Functional topography of myelin-associated glycoprotein. II. Mapping of domains on molecular fragments.

A Meyer-Franke1, M B Tropak, J C Roder, P Fischer, K Beyreuther, R Probstmeier, M Schachner.   

Abstract

The myelin-associated glycoprotein (MAG), an adhesion molecule of the immunoglobulin (Ig) superfamily with five Ig-like domains, was investigated with regard to its binding site(s) for the neuronal cell surface, collagen I, and heparin, using a panel of new monoclonal antibodies and cyanogen bromide cleavage fragments of MAG. All antibodies generated competed with each other for binding to MAG, indicating that they reacted with identical or closely related epitopes. Mapping of the reactive epitopes on recombinant deletion fragments of MAG expressed by Chinese hamster ovary (CHO) fibroblasts showed reactivity of monoclonal antibody 513 with domains I, II, and III, comprising the amino-terminal end of the extracellular domain. Monoclonal antibody 15 recognized domain III only. Binding of MAG-containing liposomes to neurons was blocked by antibodies 15 and 513. Cyanogen bromide (CNBr) fragments of domains I, II, and III bound to collagen type I under isotonic buffer conditions. CNBr fragments containing domains I and II were involved in binding to heparin. These observations suggest that domain III may be important for binding to the neuronal cell surface receptor for MAG, while domains I, II, and III interact with collagen type I and domains II and III with heparin.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7563224     DOI: 10.1002/jnr.490410304

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  6 in total

1.  Myelin-associated glycoprotein gene mutation causes Pelizaeus-Merzbacher disease-like disorder.

Authors:  Alexander Lossos; Nimrod Elazar; Israela Lerer; Ora Schueler-Furman; Yakov Fellig; Benjamin Glick; Bat-El Zimmerman; Haim Azulay; Shlomo Dotan; Sharon Goldberg; John M Gomori; Penina Ponger; J P Newman; Hodaifah Marreed; Andreas J Steck; Nicole Schaeren-Wiemers; Nofar Mor; Michal Harel; Tamar Geiger; Yael Eshed-Eisenbach; Vardiella Meiner; Elior Peles
Journal:  Brain       Date:  2015-07-15       Impact factor: 13.501

Review 2.  The role of glycoproteins in neural development function, and disease.

Authors:  K C Breen; C M Coughlan; F D Hayes
Journal:  Mol Neurobiol       Date:  1998-04       Impact factor: 5.590

Review 3.  Glycoproteins of myelin sheaths.

Authors:  R H Quarles
Journal:  J Mol Neurosci       Date:  1997-02       Impact factor: 3.444

4.  Molecular basis of the interactions of the Nogo-66 receptor and its homolog NgR2 with myelin-associated glycoprotein: development of NgROMNI-Fc, a novel antagonist of CNS myelin inhibition.

Authors:  Laurie A Robak; Karthik Venkatesh; Hakjoo Lee; Stephen J Raiker; Yuntao Duan; Jane Lee-Osbourne; Thomas Hofer; Rose G Mage; Christoph Rader; Roman J Giger
Journal:  J Neurosci       Date:  2009-05-06       Impact factor: 6.167

5.  Brain Derived Neurotrophic Factor and Superior Collicular Extract Regulate the Expression of the 1.6 Subfamily of Voltage-gated Potassium Channels in the Developing Rat Retina in vitro.

Authors:  Kavita Marita Golla; Trichur Ramaswamy Raju; Sumanthra Chatterji
Journal:  J Ophthalmic Vis Res       Date:  2012-04

6.  Posttranslational Modification of Sox11 Regulates RGC Survival and Axon Regeneration.

Authors:  Kun-Che Chang; Minjuan Bian; Xin Xia; Ankush Madaan; Catalina Sun; Qizhao Wang; Liang Li; Michael Nahmou; Takahiko Noro; Satoshi Yokota; Joana Galvao; Alexander Kreymerman; Bogdan Tanasa; Yang Hu; Jeffrey L Goldberg
Journal:  eNeuro       Date:  2021-02-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.